Evidence map›Paper›PMID 35000421›Full record

ArticleCirculation. Heart failure2022

MiR-150 Attenuates Maladaptive Cardiac Remodeling Mediated by Long Noncoding RNA MIAT and Directly Represses Profibrotic

Tatsuya Aonuma, Bruno Moukette, Satoshi Kawaguchi, Nipuni P Barupala, Marisa N Sepúlveda, Kyle Frick, Yaoliang Tang, Maya Guglin, Subha V Raman, Chenleng Cai and 3 more

Open access · greenAbstract read
In one paragraph

Article in Circulation. Heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Tatsuya AonumaDepartment of Anatomy, Cell Biology, and Physiology (T.A., B.M., S.K., N.P.B., M.N.S., I.-m.K.), Indiana University School of Medicine, Indianapolis.ORCID 0000-0002-6838-2813
Bruno MouketteDepartment of Anatomy, Cell Biology, and Physiology (T.A., B.M., S.K., N.P.B., M.N.S., I.-m.K.), Indiana University School of Medicine, Indianapolis.ORCID 0000-0002-1899-3851
Satoshi KawaguchiDepartment of Anatomy, Cell Biology, and Physiology (T.A., B.M., S.K., N.P.B., M.N.S., I.-m.K.), Indiana University School of Medicine, Indianapolis.ORCID 0000-0002-5562-115X
Nipuni P BarupalaDepartment of Anatomy, Cell Biology, and Physiology (T.A., B.M., S.K., N.P.B., M.N.S., I.-m.K.), Indiana University School of Medicine, Indianapolis.ORCID 0000-0002-7630-3089
Marisa N SepúlvedaDepartment of Anatomy, Cell Biology, and Physiology (T.A., B.M., S.K., N.P.B., M.N.S., I.-m.K.), Indiana University School of Medicine, Indianapolis.ORCID 0000-0003-3486-9508
Kyle FrickKrannert Institute of Cardiology (K.F., M.G., S.V.R., I.-m.K.), Indiana University School of Medicine, Indianapolis.
Yaoliang TangVascular Biology Center, Medical College of Georgia, Augusta University (Y.T.).ORCID 0000-0002-8372-1545
Maya GuglinKrannert Institute of Cardiology (K.F., M.G., S.V.R., I.-m.K.), Indiana University School of Medicine, Indianapolis.
Subha V RamanKrannert Institute of Cardiology (K.F., M.G., S.V.R., I.-m.K.), Indiana University School of Medicine, Indianapolis.
Chenleng CaiWells Center for Pediatric Research (C.C., I.-m.K.), Indiana University School of Medicine, Indianapolis.ORCID 0000-0001-6900-4737
Suthat LiangpunsakulDivision of Gastroenterology and Hepatology (S.L.), Indiana University School of Medicine, Indianapolis.ORCID 0000-0002-6504-8123
Shinichi NakagawaRNA Biology Laboratory, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan (S.N.).ORCID 0000-0002-6806-7493
Il-Man KimDepartment of Anatomy, Cell Biology, and Physiology (T.A., B.M., S.K., N.P.B., M.N.S., I.-m.K.), Indiana University School of Medicine, Indianapolis.ORCID 0000-0002-9268-8337
Indiana University – Purdue University Indianapolis · USAsahikawa Medical University · JPAugusta University · USHokkaido Pharmaceutical University · JPRichard L. Roudebush VA Medical Center · US

Funding

Beta-arrestin signaling and microRNA biogenesis in cardioprotectionR01HL124251 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI KIM, IL-MAN · 2014 to 2018
$1.9M
Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failureR01HL146481 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI KIM, IL-MAN · 2019 to 2022
$1.6M
American Heart Association-American Stroke Association 18TPA34170104American Heart Association-American Stroke Association 900453American Heart Association-American Stroke Association 931621NHLBI NIH HHS R01 HL124251NHLBI NIH HHS R01 HL146481
6 · The paper itself

Abstract

backgroundMicroRNA-150 (miR-150) plays a protective role in heart failure (HF). Long noncoding RNA, myocardial infarction-associated transcript (MIAT) regulates miR-150 function in vitro by direct interaction. Concurrent with miR-150 downregulation, MIAT is upregulated in failing hearts, and gain-of-function single-nucleotide polymorphisms in MIAT are associated with increased risk of myocardial infarction (MI) in humans. Despite the correlative relationship between MIAT and miR-150 in HF, their in vivo functional relationship has never been established, and molecular mechanisms by which these 2 noncoding RNAs regulate cardiac protection remain elusive.

methodsWe use MIAT KO (knockout),

resultsUsing novel mouse models, we demonstrate that genetic overexpression of MIAT worsens cardiac remodeling, while genetic deletion of MIAT protects hearts against MI. Importantly, miR-150 overexpression attenuates the detrimental post-MI effects caused by MIAT. Genome-wide transcriptomic analysis of MIAT null mouse hearts identifies

conclusionsOur findings delineate a pivotal functional interaction among MIAT, miR-150, and

Indexed as

Heart FailureHomeodomain ProteinsMicroRNAsMyocardial InfarctionRNA, Long NoncodingTranscription FactorsAnimalsDisease Models, AnimalHumansMiceVentricular RemodelingHomeodomain ProteinsHOXA4 protein, humanHoxa4 protein, mouseMiat long non-coding RNAMicroRNAsMIR150, humanMirn150 microRNA, mouseRNA, Long NoncodingTranscription FactorscarvedilolfibroblastsmicroRNAsRNA, untranslatedtranscriptome

Identifiers

PMID35000421
PMCPMC9018469
OpenAlexW4206286459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.